Align possesses pricing power in its core Clear Aligner business, able to raise ASPs while simultaneously growing volume and doctor submitters even as management acknowledges orthodontic starts have declined for four consecutive years. This combination suggests the Invisalign brand commands enough clinical differentiation and patient demand that doctors continue prescribing it at higher prices despite a softening orthodontic market.
the thesis · admitted · the reason above is the thesis, not printed twice
no findingread · nothing bore on it
It held on this filing. No finding was written because nothing in it bore on the reason — the sentences it was read against are below.
the evidence · every sentence checkedthree sentences · whole, uncut
the claims it rests on · in our words, not the filing’s